
← PsychRounds: The Psychiatry Podcast5. Aug. · 28 Min.
Centanafadine (Simtriyo): A New Medication for ADHD
<p>Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.</p><p><br></p><p><strong>References</strong> </p><p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/"><u>https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/</u></a></p><p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/"><u>https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/</u></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/31776871/"><u>https://pubmed.ncbi.nlm.nih.gov/31776871/</u></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/40619095/"><u>https://pubmed.ncbi.nlm.nih.gov/40619095/</u></a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/28731336/"><u>https://pubmed.ncbi.nlm.nih.gov/28731336/</u></a></p><p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9426730/"><u>https://pmc.ncbi.nlm.nih.gov/articles/PMC9426730/</u></a></p>